l 158809 has been researched along with Cardiomegaly in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heller, LJ; Lear, PM; Prohaska, JR | 1 |
| Buttrick, PM; Geenen, DL; Malhotra, A | 1 |
| Ishikawa, K; Kai, T; Kurooka, A; Shimada, S; Sugimura, K; Takenaka, T | 1 |
| Gerdes, AM; Harris, J; Lu, W; Said, S; Tamura, T | 1 |
4 other study(ies) available for l 158809 and Cardiomegaly
| Article | Year |
|---|---|
Cardiac hypertrophy in copper-deficient rats is not attenuated by angiotensin II receptor antagonist L-158,809.
Topics: Analysis of Variance; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Cardiomegaly; Copper; Coronary Circulation; Dopamine; Heart Ventricles; Imidazoles; Iron; Liver; Male; Organ Size; Rats; Tetrazoles; Vascular Resistance | 1996 |
Angiotensin receptor 1 blockade does not prevent physiological cardiac hypertrophy in the adult rat.
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Blotting, Northern; Body Weight; Cardiomegaly; Contractile Proteins; Female; Heart Rate; Imidazoles; Myocardial Contraction; Organ Size; Physical Conditioning, Animal; Protein Kinase C; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles | 1996 |
Inhibitory effects of a subdepressor dose of L-158,809, an angiotensin II type 1 receptor antagonist, on cardiac hypertrophy and nephropathy via the activated human renin-angiotensin system in double transgenic mice with hypertension.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Cardiomegaly; Humans; Hypertension; Imidazoles; Kidney; Male; Mice; Mice, Transgenic; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles | 1998 |
Reverse remodeling of cardiac myocyte hypertrophy in hypertension and failure by targeting of the renin-angiotensin system.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiomegaly; Echocardiography; Enalapril; Female; Heart Failure; Hypertension, Renal; Imidazoles; Muscle Fibers, Skeletal; Myocardium; Organ Size; Rats; Rats, Inbred Strains; Renin-Angiotensin System; Tetrazoles; Ventricular Remodeling | 2000 |